Mine & Arao Wealth Creation & Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10
Closed -$165 395
2023
Q4
$165 Hold
10
﹤0.01% 316
2023
Q3
$78 Hold
10
﹤0.01% 316
2023
Q2
$53 Hold
10
﹤0.01% 328
2023
Q1
$54 Hold
10
﹤0.01% 324
2022
Q4
$37 Hold
10
﹤0.01% 320
2022
Q3
$0 Hold
10
﹤0.01% 349
2022
Q2
$0 Hold
10
﹤0.01% 337
2022
Q1
$0 Hold
10
﹤0.01% 327
2021
Q4
$0 Hold
10
﹤0.01% 325
2021
Q3
$0 Hold
10
﹤0.01% 296
2021
Q2
$0 Hold
10
﹤0.01% 293
2021
Q1
$1K Hold
10
﹤0.01% 268
2020
Q4
$0 Hold
10
﹤0.01% 274
2020
Q3
$0 Hold
10
﹤0.01% 270
2020
Q2
$1K Hold
10
﹤0.01% 233
2020
Q1
$1K Hold
10
﹤0.01% 228
2019
Q4
$1K Buy
+10
New +$1.22K ﹤0.01% 237

Mine & Arao Wealth Creation & Management's ORTX Position: Q1 2024 in Review

Mine & Arao Wealth Creation & Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 10 shares — an estimated $165 sold.

Mine & Arao Wealth Creation & Management first reported a position in ORTX in Q4 2019 and held it in 17 quarters. The position peaked at $1K in Q1 2021. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.

  • Mine & Arao Wealth Creation & Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
  • Mine & Arao Wealth Creation & Management sold 10 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $165.
  • Mine & Arao Wealth Creation & Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2019 and held it in 17 quarters.
  • Mine & Arao Wealth Creation & Management's Orchard Therapeutics plc American Depositary Shares position peaked at $1K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.

Based on Mine & Arao Wealth Creation & Management's 13F filing for Q1 2024, filed 9 May 2024.